Antag lands €80m to advance GIPR antagonist ap
Author: Michael
World’s largest longevity event combines longe
Funding call for innovative scientific proposals
The Longevity Clinics panel session at this year
Prenuvo study links Type 2 diabetes to reduction
How supplements are reshaping healthspan strateg
Company lists on Nasdaq, raising $11m to take pa
A new documentary on the frontiers of longevity
Developer of FOXO3 activators initially targets
Methuselah Foundation backs mouse study explorin